I suppose that would depend on your definition of Soon. But I'm willing to wait.
No other company in the OTC has such a small share structure, let alone float, with real products you can buy and engage with, with a $100mil + a year parent company and their leadership that got them there also running a public OTC company.
My bet is on the $100mil + executive team and not random Ihubbers.
They've been diligent thus far, and obviously know how to scale businesses. GMER is not a dilution machine like most OTCs.
So overall, I'm happy to ride it out and let them develop this into something big like they've done over 7 times before with their other companies.
And if all else fails, ViaOne officers own a bunch of GMER, so they could always take the golden pill and RM ViaOne into GMER and they make out well on the new valuation it would fetch. And so would we.
News 
Market Data 
Discover 
